A spokesman for the medical-technology industry warned that a new medical-device tax that goes into effect in 2013 under the Obama health-care law could force some companies to cut jobs.
Blood-testing equipment maker Immucor says it agreed to be acquired by TPG Capital in a deal worth $1.97 billion, or $27 per share in cash.
A new test developed by a unit of biotech company Life Technologies has shown success in quickly pinpointing the strain of E. coli involved in a European outbreak that has killed 25 people and sickened more than 2,400 worldwide.